International Journal of Gynecological Cancer

Progress in ovarian cancer research: Proceedings of the 5th Biennial Ovarian Cancer Research Symposium
pp. 463-469(7)
Authors: DISIS,; RIVKIN,; BARON,; MARKMAN,; CONNOLLY,; UELAND,; KOHN,; TRIMBLE,; BEREK,

Guidelines for gynecological cancer—an audit of current network documents in England and Wales
pp. 470-477(8)
Authors: LEESON,; EDMONDSON,; HEATLEY,; NUNNS,; ROLLASON,; REYNOLDS,; SEDDON,; WHITAKER,; KEHOE,

Symptomatic osteoradionecrosis of pelvic bones in patients with gynecological malignancies—result of a long-term follow-up
pp. 478-483(6)
Authors: FELTL,; VOŠMIK,; JIRÁSEK,; STÁHALOVÁ,; KUBEŠ,

Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer?
pp. 484-489(6)
Authors: AYHAN,; TASKIRAN,; YIGIT-CELIK,; BOZDAG,; GULTEKIN,; USUBUTUN,; GULER,; YUCE,

Long-term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures
pp. 490-495(6)
Authors: TENTES,; MIRELIS,; MARKAKIDIS,; BEKIARIDOU,; BOUGIOUKAS,; XANTHOULIS,; TSALKIDOU,; ZAFIROPOULOS,; NIKAS,

The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer
pp. 496-500(5)
Authors: BARLOW,; PRZYBYLSKI,; SCHILDER,; MOORE,; LOOK,

Clinicopathologic study of the putative precursor lesions of epithelial ovarian cancer in low-risk women
pp. 501-506(6)
Authors: TOK,; ERTUNC,; TATAROGLU,; YAZICI,; KANAT,; DILEK,

Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer
pp. 507-514(8)
Authors: POOLE,; PERREN,; GAWANDE,; RIDDERHEIM,; COOK,; JENKINS,; ROYCHOWDHURY,

Unfavorable prognostic value of CD24 expression in sections from primary and relapsed ovarian cancer tissue
pp. 515-521(7)
Authors: SUROWIAK,; MATERNA,; KAPLENKO,; SPACZYŃSKI,; DIETEL,; KRISTIANSEN,; LAGE,; ZABEL,

Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1
pp. 522-531(10)
Authors: ZHANG,; LIN,; DI,

Arsenic trioxide–loaded, microemulsion-enhanced cytotoxicity on MDAH 2774 ovarian carcinoma cell line
pp. 532-537(6)
Authors: TEREK,; KARABULUT,; SELVI,; AKMAN,; KARASULU,; OZGUNEY,; SANLI,; USLU,; OZSARAN,

Synergistic antitumor effect of tumor necrosis factor–related apoptosis-inducing ligand combined with cisplatin in ovarian carcinoma cell lines in vitro and in vivo
pp. 538-548(11)
Authors: LIU,; MAO,; HOU,

Expression of cyclooxygenase-2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas: is there any correlation with angiogenesis or clinicopathologic parameters?
pp. 549-555(7)
Authors: ÖZEL,; PEŞTERELI,; ŞIMŞEK,; ERDOğAN,; KARAVELI,

Computerized nuclear morphometry for the prediction of inguinal lymph nodes metastases in squamous cell carcinoma of the vulva
pp. 556-561(6)
Authors: LAVIE,; MAINI,; PILIP,; COMERCI,; SABO,; CROSS,; DAWLATLY,; LOPES,; AUSLENDER,

Gene expression patterns in advanced human cervical cancer
pp. 562-567(6)
Authors: GRIGSBY,; WATSON,; POWELL,; ZHANG,; RADER,

Risk factors of having high-grade cervical intraepithelial neoplasia/invasive carcinoma in women with atypical glandular cells of undetermined significance smears
pp. 568-574(7)
Authors: CHICHAREON,; TOCHAROENVANICH,

Angiogenesis in cervical intraepithelial neoplasia and early-staged uterine cervical squamous cell carcinoma: clinical significance
pp. 575-580(6)
Authors: TRIRATANACHAT,; NIRUTHISARD,; TRIVIJITSILP,; TRESUKOSOL,; JARURAK,

Angiomyofibroblastoma of the vagina in a postmenopausal breast cancer patient treated with tamoxifen: clinicopathologic analysis of a case and review of the literature
pp. 581-585(5)
Authors: VARRAS,; AKRIVIS,; DEMOU,; KITSIOU,; ANTONIOU,

Investigation of human papillomavirus by hybrid capture II in cervical carcinomas including 113 adenocarcinomas and related lesions
pp. 586-590(5)
Authors: MOREIRA,; LONGATO-FILHO,; TAROMARU,; QUEIROZ,; JUBÉ,; PINTO,; SCHMITT,

Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia
pp. 591-598(8)
Authors: MONSONEGO,; PINTOS,; SEMAILLE,; BEUMONT,; DACHEZ,; ZERAT,; BIANCHI,; FRANCO,

Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention
pp. 599-603(5)
Authors: MOREIRA,; OLIVEIRA,; FERRAZ,; COSTA,; COSTA FILHO,; KARIC,

Correlation of human papillomavirus and adeno-associated virus 2 infection in cytology with Korean women
pp. 604-609(6)
Authors: HYUN-SUN,; HEUNG-JAE,; BYUNG-HUN,; YOUNG-LAE,; GYE-HYUN,; HO-SUN,; CHONG-KOOK,; BYOUNG-DON,; SU-MI,; WOONG-SHICK,

Correlation between MRI and histopathologic findings in stage I cervical carcinomas: influence of stromal desmoplastic reaction
pp. 610-614(5)
Authors: ITOH,; SHIOZAWA,; OHIRA,; SHIOHARA,; KONISHI,

Long-term follow-up after large-loop excision of the transformation zone: evaluation of 22 years treatment of high-grade cervical intraepithelial neoplasia
pp. 615-619(5)
Authors: vanHAMONT,; vanHAM,; STRUIK-van derZANDEN,; KEIJSER,; BULTEN,; MELCHERS,; MASSUGER,

Chronic pelvic pain: a rare complication following a large-loop excision of the transformation zone
pp. 620-622(3)
Authors: SIEUNARINE,; LAWTON,; SMITH,

Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy
pp. 623-630(8)
Authors: NARAYAN,; FISHER,; BERNSHAW,

Neoadjuvant chemotherapy in cervical cancer: a 67 patients experience
pp. 631-637(7)
Authors: SELVAGGI,; LOIZZI,; DI GILIO,; NARDELLI,; CANTATORE,; CORMIO,

Hyperbaric oxygen therapy for delayed radiation injuries in gynecological cancers
pp. 638-642(5)
Authors: FINK,; CHETTY,; LEHM,; MARSDEN,; HACKER,

Micrometastases detected by cytokeratin 19 expression in sentinel lymph nodes of patients with early-stage cervical cancer
pp. 643-648(6)
Authors: WANG,; SUN,; LU,; SHI,; OU,; REN,; FU,

Sentinel node identification in cervical cancer patients undergoing transperitoneal radical hysterectomy: a study of 100 cases
pp. 649-654(6)
Authors: WYDRA,; SAWICKI,; WOJTYLAK,; BANDURSKI,; EMERICH,

The risk of residual neoplasia in women with microinvasive squamous cervical carcinoma and positive cone margins
pp. 655-659(5)
Authors: PHONGNARISORN,; SRISOMBOON,; KHUNAMORNPONG,; SIRIAUNGKUL,; SUPRASERT,; CHAROENKWAN,; CHEEWAKRIANGKRAI,; SIRIAREE,; PANTASRI,

Human immunodeficiency virus testing in patients with invasive cervical carcinoma: a prospective trial of the gynecologic oncology group
pp. 660-663(4)
Authors: CALKINS,; STEHMAN,; BUNDY,; BENDA,; MANNEL,; SEAGO,; CAPPUCCINI,; ALVAREZ,; MONK,; MAIMAN,

Analyses of atypical squamous cells refined by the 2001 Bethesda System: the distribution and clinical significance of follow-up management
pp. 664-669(6)
Authors: LEE,; JUNG,; SONG,; KIM,; PARK,; BAE,

Radiation-induced benign glandular cells in posthysterectomy smears: a cytomorphologic and clinical analysis
pp. 670-674(5)
Authors: YAVUZ,; OZLÜK,; KÜÇÜCÜK,; TUZLALI,; AKHAN,; ILHAN,; TOPUZ,; İPLIKÇI,

Female circumcision (female genital mutilation): a problem for brachytherapy in cervical cancer
pp. 675-680(6)
Authors: MANJI,; AL BADAWI,; EL ENBABY,; AL BAREEDY,

Acceptability of human immunodeficiency virus testing in patients with invasive cervical cancer in Kenya
pp. 681-685(5)
Authors: GICHANGI,; ESTAMBALE,; BWAYO,; ROGO,; OJWANG,; NJUGUNA,; TEMMERMAN,

Multinucleation of koilocytes is actually multilobation
pp. 686-689(4)
Authors: CHO,; KANG,; HONG,; JEONG,; CHOI,

Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cells
pp. 690-697(8)
Authors: YIM,; LEE,; KIM,; PARK,

Distinctive cell cycle regulatory protein profiles by adenovirus delivery of p53 in human papillomavirus–associated cancer cells
pp. 698-707(10)
Authors: JIN,; BAE,; KIM,; LEE,; NAMKOONG,; HAN,; CHUN,; AHN,

Phenotypic features with p53 alterations related to human papillomavirus and prognostic evaluation in cervical cancer
pp. 708-717(10)
Authors: LU,; FEKI,

Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells
pp. 718-729(12)
Authors: BAI,; WEI,; WANG,; LI,; HE,

Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis
pp. 730-735(6)
Authors: LAI,; PENG,; NIEH,; YU,; CHANG,; LIN,; SUN,; CHU,

Molecular variants of human papillomavirus type 16 and risk for cervical neoplasia in South Africa
pp. 736-742(7)
Authors: TU,; KUHN,; DENNY,; BEATTIE,; LORINCZ,; WRIGHT,

Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo
pp. 743-751(9)
Authors: NIU,; PENG,; DUAN,; WANG,

Erythropoietin receptor expression in biopsy specimens from patients with uterine cervix squamous cell carcinoma
pp. 752-756(5)
Authors: SHENOUDA,; MEHIO,; SOUHAMI,; DUCLOS,; PORTELANCE,; BELENKOV,; CHOW,

Association between CD31 expression and histopathologic features in stage IB squamous cell carcinoma of the cervix
pp. 757-762(6)
Authors: SILVA-FILHO,; TRAIMAN,; TRIGINELLI,; REIS,; PEDROSA,; MIRANDA,; ABREU,; MACARENCO,; CUNHA-MELO,

Inactivation of Crk SH3 domain-binding guanine nucleotide-releasing factor (C3G) in cervical squamous cell carcinoma
pp. 763-771(9)
Authors: OKINO,; NAGAI,; NAKAYAMA,; DOI,; YONEYAMA,; KONISHI,; TAKESHITA,

Increased cyclooxygenase-2 expression is correlated with suppressed antitumor immunity in cervical adenocarcinomas
pp. 772-779(8)
Authors: CHEN,; FUKUHARA,; MANDAI,; MATSUMURA,; KARIYA,; TAKAKURA,; FUJII,

the management of vulval intraepithelial neoplasia in Northern Ireland
pp. 780-785(6)
Authors: ZAWISLAK,; PRICE,; DOBBS,; McCLELLAND,; McCLUGGAGE,

A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia
pp. 786-790(5)
Authors: NAIK,; NIXON,; LOPES,; GODFREY,; HATEM,; MONAGHAN,

Genital human papillomavirus infection in the male sexual partners of women with isolated vulvar lesions
pp. 791-794(4)
Authors: TANER,; TASKIRAN,; ONAN,; ULUTURK,; HIMMETOGLU,

The role of omentectomy and appendectomy during the surgical staging of clinical stage I endometrial cancer
pp. 795-798(4)
Authors: DILEK,; DEDE,; DEVECI,; YENEN,

Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer
pp. 799-804(6)
Authors: NOMURA,; AOKI,; SUZUKI,; SUSUMU,; TAMADA,; KATAOKA,; HIGASHIGUCHI,; EZAWA,; NOZAWA,

Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors?
pp. 805-808(4)
Authors: AYHAN,; TASKIRAN,; SIMSEK,; SEVER, ATIKE

The effect of long-term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia
pp. 809-813(5)
Authors: BESE,; VURAL,; OZTURK,; DAGISTANLI,; DEMIRKIRAN,; TUNCDEMIR,; ARVAS,; SANIOGLU,; KOSEBAY,

Uterine effects of tamoxifen: a prospective study
pp. 814-820(7)
Authors: MCGONIGLE,; SMITH,; MARX,; MORGAN,; VASILEV,; ROY,; WONG,; SIMPSON,; WILCZYNSKI,

Neuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometrium
pp. 821-826(6)
Authors: TAMURA,; JOBO,; WATANABE,; KANAI,; KURAMOTO,

Expression of estrogen receptor–related receptor isoforms and clinical significance in endometrial adenocarcinoma
pp. 827-833(7)
Authors: GAO,; SUN,; WANG,; ZHAO,; WEI,

Genome-wide analysis of deoxyribonucleic acid in endometrial cancer using comparative genomic hybridization microarrays
pp. 834-842(9)
Authors: O'TOOLE,; DUNN,; SHEPPARD,; KLOCKER,; BEKTIC,; SMYTH,; MARTIN,; SHEILS,; O'LEARY,

Euonymus alatus (Thunb.) Sieb induces apoptosis via mitochondrial pathway as prooxidant in human uterine leiomyomal smooth muscle cells
pp. 843-848(6)
Authors: KIM,; KWON,; KANG,; JIN,; SUH,; LEE,

p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas
pp. 849-853(5)
Authors: ANDERSON,; NONAKA,; CHUAI,; OLSHEN,; CHI,; SABBATINI,; SOSLOW,

Whole-body positron emission tomography with F-18 fluorodeoxyglucose for the detection of recurrence in uterine sarcomas
pp. 854-860(7)
Authors: MURAKAMI,; TSUKADA,; SHIDA,; WATANABE,; MAEDA,; KOIDO,; HIRASAWA,; MURAMATSU,; MIYAMOTO,; NASU,; YASUDA,; KAJIWARA,; IDE,

Uterine sarcomas in breast cancer patients treated with tamoxifen
pp. 861-865(5)
Authors: ARENAS,; ROVIROSA,; HERNÁNDEZ,; ORDI,; JORCANO,; MELLADO,; BIETE,

Evolution of treatment of high-risk metastatic gestational trophoblastic tumors: Ain Shams University experience
pp. 866-874(9)
Authors: EL-LAMIE,; EL SAYED,; BADAWIE,; BAYOMI,; EL-GHAZALY,; KHALAF-ALLAH,; EL-MAHALLAWY,

Gestational trophoblastic tumor in pregnancy: a case report and review of the literature
pp. 875-881(7)
Authors: DY ECHO,; SORIANO-ESTRELLA,

The role of hysterotomy in the management of gestational trophoblastic neoplasia
pp. 882-883(2)
Authors: TJALMA,; VERMORKEN,

Leiomyosarcoma of the vagina: case report and literature review
pp. 884-891(8)
Authors: AHRAM,; LEMUS,; SCHIAVELLO,

Skeletal carcinomatosis in endometrial clear cell carcinoma at initial presentation: a case report
pp. 891-895(5)
Authors: DURSUN,; GÜLTEKIN,; YÜCE,; AYHAN,

A case of high-grade endometrial stromal sarcoma arising from endometriosis in the cul-de-sac
pp. 895-899(5)
Authors: KUSAKA,; MIKUNI,; NISHIYA,

Recurrence of carcinoma cervix in the scar of previous cesarean section: a case report
pp. 900-904(5)
Authors: PRADHAN,; ASTHANA,; SHARAN,; KUMAR,; SHARMA,

Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature
pp. 905-908(4)
Authors: CALUWAERTS,; VAN CALSTEREN,; MERTENS,; LAGAE,; MOERMAN,; HANSSENS,; WUYTS,; VERGOTE,; AMANT,

Spontaneous bacterial peritonitis following treatment for cervical carcinoma
pp. 908-911(4)
Authors: MICHA,; GOLDSTEIN,; RETTENMAIER,; BROWN,; BOCK,

Splenic metastases from cervical carcinoma: a case report
pp. 911-914(4)
Authors: GUPTA,; NAIR,; FUKE,; BEDRE,; BASU,; SHRIVASTAVA,

Metastatic tumor extending through the inferior vena cava into the right atrium: a case report of carcinoma of the uterine cervix with para-aortic lymph node metastases
pp. 914-916(3)
Authors: NAKAO,; YOKOYAMA,; YASUNAGA,; HARA,; NAKAHASHI,; IWASAKA,

Synchronous cervical and vulvar malign melanomas: metastasis or multifocality of the disease? A case report and review of the literature
pp. 917-920(4)
Authors: AKOZ,; AYAS,; EREN,; BILGIC,

Pleomorphic adenoma of the vulva: a review illustrated by a clinical case
pp. 920-923(4)
Authors: DYKGRAAF,; vanVEEN,; vanBEKKUM-deJONGE,; GERRETSEN,; deJONG,; BURGER,

Primary malignant lymphoma of uterine cervix
pp. 923-927(5)
Authors: CANTÚ DE LEÓN,; PÉREZ MONTIEL,; CHANONA VILCHIS,

Preoperative needle biopsy and immunohistochemical analysis for gastrointestinal stromal tumor of the rectum mimicking vaginal leiomyoma
pp. 927-930(4)
Authors: TAKANO,; SAITO,; KITA,; FURUYA,; AIDA,; KIKUCHI,

Recurrent vulval congenital lymphangioma circumscriptum—a case report and literature review
pp. 930-934(5)
Authors: ROY,; AGARWAL,; KUMAR,; MALHOTRA,; GOPENDRU,

Is early postradiation dysplasia almost associated with poor prognosis? A case report and review of the literature
pp. 934-936(3)
Authors: AKSU,; FAYDA,; SAYNAK,; TORE,; ALATLI,

Successful treatment of two patients with gestational trophoblastic neoplasm presenting with emergent neurologic symptoms
pp. 937-940(4)
Authors: GHAEMMAGHAMI,; BEHTASH,; AYATOLLAHI,; HANJANI,

Recurrent partial hydatidiform mole: a report of a patient with three consecutive molar pregnancies
pp. 940-943(4)
Authors: KOC,; OZDEGIRMENCI,; TULUNAY,; OZGUL,; KOSE,; BULBUL,

The impact of obesity on surgery in gynecological oncology: a review
pp. 944-952(9)
Authors: PAPADIA,; RAGNI,; SALOM,

Erratum
pp. 953-953(1)